As part of the Global Fund Replenishment Conference, leading experts discussed how a more collaborative approach toward HIV and hepatitis elimination can help better utilize health resources and achieve optimal health outcomes.
Viral hepatitis is a leading cause of death globally, killing more than 1.4 million people each year. By 2040, deaths from hepatitis will exceed that of HIV, TB and malaria combined if the status quo persists.
During the session, it was concluded that effective global health programs should utilize a people-centered, rather than disease-centered approach and that elimination of viral hepatitis should be part of Universal Health Coverage. Currently, testing and treatment for hepatitis is affordable and high impact. Recommendations to the Global Fund included: supporting elimination goals for HCV and HBV among people with TB and people living with HIV; ensuring that services funded by the Global Fund provide prevention and treatment for HIV, TB and hepatitis; and utilizing Global Fund procurement systems to reduce the commodity price for hepatitis diagnostics and treatment.
The World Health Organisation report summarizing these conclusions can be found here.